HOME / INVESTOR RELATIONS / PRESS RELEASES
Press releases
In this section, you can find Press Releases concerning Neopharmed Gentili’s financial and corporate updates.
June 29, 2026
Notice of full redemption of Neopharmed Gentili S.P.A. of its Senior Secured Fixed Rate Notes due 2030 and its Senior Secured Floating Rate Notes due 2030
June 18, 2026
Neopharmed Gentili S.P.A. successfully completes the placement of its €890.0 million senior secured floating rate notes due 2033
June 15, 2026
Neopharmed Gentili S.p.A. Announces an offering of Senior Secured Floating Rate Notes due 2033
May 4, 2026
Neopharmed Gentili – through its Irish affiliate – acquires exclusive rights to Navenibart in Europe from BioCryst Pharmaceuticals
December 18, 2025
October 01, 2025
Neopharmed Gentili Completes Acquisition of European ORLADEYO® Business from BioCryst Pharmaceuticals
June 27, 2025
February 14, 2025
Neopharmed Gentili announces the private placement of €100.0 million Senior Secured Notes due 2030
May 16, 2024
Neopharmed Gentili S.p.A. – Creation of first ranking pledge over the share capital of Neopharmed Gentili S.p.A. and Valeas S.p.A.
March 28, 2024
Neopharmed Gentili S.P.A. successfully completes the placement of its €750.0 million senior secured notes due 2030
Disclaimer
IMPORTANT NOTICE: You must read the following information before continuing.
Access to the information and documents on the portion of our website that follows this disclaimer (the “IR Section”) is restricted for regulatory reasons. By accessing the IR Section you will be deemed to have read and accepted the terms of this disclaimer. The information contained in the IR Section and in the reports, financial statements, press releases, presentations and other documents available in the IR Section (the “Information”) does not constitute an offer to sell or a solicitation of an offer to buy any securities of Neopharmed S.p.A. (the “Company”) or any of its subsidiaries or affiliates. You must comply with all laws that apply to you in any place in which you buy, offer or sell any securities or access or possess the Information.
Any securities referred to in the Information have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may be offered or sold only to investors who are either (i) qualified institutional buyers (within the meaning of Rule 144A under the Securities Act) in the United States or (ii) outside the United States in offshore transactions in accordance with Regulation S under the Securities Act (and, if investors are resident in a member state of the European Economic Area, a qualified investor, within the meaning of Article 2(e) of Regulation (EU) 2017/1129, as amended, and any relevant implementing measure in each member state of the European Economic Area).
You acknowledge that the information and statements contained in the document you are accessing on this website speak only as of the date of such document (or such other date(s) specified therein), and such information and statements may become inaccurate, stale and/or out-of-date thereafter and should not be relied upon for any investment decision. You acknowledge that the materials on this website that you are accessing are confidential and intended only for you and you agree you will not forward, reproduce, copy, download or publish any of such materials (electronically or otherwise) to any other person if this is not in accordance with the law.
You acknowledge that the access to information and documents contained on this portion of the website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access this portion of the website. If you are not authorized to access the information and document contained on this portion of the website or you are not sure that you are permitted to view these materials, you should leave this portion of the website.
You acknowledge that no registration or approval has been obtained and the Company and its affiliates assume no responsibility if there is a violation of applicable law and regulation by any person.
By clicking the button below labeled “Yes”, you are confirming that you have read and understood the disclaimer above.
If you cannot so confirm, you must click the button labelled “No” or otherwise exit this portion of the website.